Senior Director, Viral Gene Therapy, FUJIFILM Diosynth Biotechnologies
Michael is responsible for overseeing FUJIFILM Diosynth Biotechnologies’ (FDB) Viral Gene Therapy operations in the UK. Prior to this he spent 4 years at FDB’s College Station location in Texas USA where he was Head of Process Development, and was responsible for leading a rapidly expanding process development team. He has previously served in a number of technical roles at FDB’s sites in Texas and the UK and before joining FDB, worked for MSD Biologics and Avecia Biotechnology. Michael gained a BSc in Medical Microbiology and Immunology and an MPhil in Developmental Biology from Newcastle University.
Stevenage Bioscience Catalyst30 November 2023